Development of heart failure with preserved ejection fraction in type 2 diabetic mice is ameliorated by preserving vascular function-Reference-Cited by-同舟云学术

Development of heart failure with preserved ejection fraction in type 2 diabetic mice is ameliorated by preserving vascular function

Published:2021-11 Issue: Volume:284 Page:119925
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Otto Mandy,Brabenec Laura,Müller Melanie,Kintrup Sebastian,Hellenthal Katharina E.M.,Holtmeier Richard,Steinbuch Sophie Charlotte,Karsten Ole Sönken,Pryvalov Heorhii,Rossaint Jan,Gross Eric R.,Wagner Nana-Maria

Funder

National Institute of General Medical Sciences

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference36 articles.

1. Trends in diabetes management among US adults: 1999–2018;Fang;N. Engl. J. Med.,2021

2. The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: a systematic review and meta-analysis;Bouthoorn;Diabetes Vasc. Dis. Res.,2018

3. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the European Society of Cardiology;Paulus;Eur. Heart J.,2007

4. Microvascular dysfunction in heart failure with preserved ejection fraction;D’Amario;Front. Physiol.,2019

5. Trends in prevalence and outcome of heart failure with preserved ejection fraction;Owan;N. Engl. J. Med.,2006

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roles of cMyBP-C phosphorylation on cardiac contractile dysfunction in db/db mice;Journal of Molecular and Cellular Cardiology Plus;2024-06

2. Influence of cerebral small vessel disease on functional outcome and recurrence of cerebral infarction in patients with type 2 diabetes;International Journal of Diabetes in Developing Countries;2023-11-21

3. Transient receptor potential vanilloid type 1: cardioprotective effects in diabetic models;Channels;2023-11-20

4. FFAR4 regulates cardiac oxylipin balance to promote inflammation resolution in HFpEF secondary to metabolic syndrome;Journal of Lipid Research;2023-06

5. Roles of hydroxyeicosatetraenoic acids in diabetes (HETEs and diabetes);Biomedicine & Pharmacotherapy;2022-12